Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-03-11 to 2022-09-30
Current total value of award: $172164.93
Description: PYLARIFY INJECTION (PIFLUFOLASTAT F18)